← Scroll for more →
Collegium Pharmaceutical, Inc (COLL)
Pharmaceutical Preparations
Latest Price
$23.80
TTM P/E
18.89
Normalized P/E
32.12
TTM Div Yield
--
Fwd Div Yield
--
Book Value
9.62
P/B Ratio
2.47
Valuation metrics
adjust assumptions →EPS: $1.73
Book value / share: $9.51
Formula: √(22.5 × EPS × BVPS)
Graham Number
$19.24
20% downside
Norm. op. income: $56M (median of 7yr)
Tax rate: 31%
Discount rate: 10%
Growth assumption: zero (EPV is a no-growth value)
Earnings Power Value
$24.08
+0% upside
Base FCF: $203M (median of recent 5yr)
Growth: 23%/yr (median YOY, capped at 25%)
Discount rate: 10%
Terminal growth: 3%
Projection horizon: 10 years
DCF Fair Value
$419.86
+1647% upside
EPS: $1.73
Target P/E: 32×
Formula: EPS × P/E
P/E Fair Value
$55.36
+130% upside
Institutional Ownership
100.0% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BlackRock, Inc. | 5.44M | $196.0M | 16.74% | +307.2K | 2026-06-30 |
| Jupiter Topco LLC | 2.15M | $77.0M | 6.61% | -- | 2026-06-30 |
| Invesco Ltd. | 1.88M | $68.0M | 5.79% | +290.6K | 2026-06-30 |
| Fuller & Thaler Asset Management, Inc. | 1.63M | $59.0M | 5.02% | +133.2K | 2026-06-30 |
| Principal Financial Group Inc | 1.63M | $59.0M | 5.02% | +337.3K | 2026-06-30 |
| State Street Corp | 1.53M | $55.0M | 4.70% | +104.3K | 2026-06-30 |
| Massachusetts Financial Services Co | 1.41M | $50.0M | 4.33% | +39.6K | 2026-06-30 |
| Vanguard Capital Management LLC | 1.38M | $50.0M | 4.25% | +47.3K | 2026-06-30 |
| Renaissance Technologies LLC | 1.37M | $49.0M | 4.20% | -102.9K | 2026-06-30 |
| Eventide Asset Management, LLC | 1.36M | $49.0M | 4.19% | -63.1K | 2026-06-30 |